QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (46) Citing Articles via Google Scholar Google Scholar Articles by Heimer, G. Articles by Bergman, H. Search for Related Content PubMed PubMed Citation Articles by Heimer, G. Articles by Bergman, H.

 Previous Article  |  Next Article 

The Journal of Neuroscience, September 15, 2002, 22(18):7850-7855

BRIEF COMMUNICATION
Dopamine Replacement Therapy Reverses Abnormal Synchronization of Pallidal Neurons in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Primate Model of Parkinsonism

Gali Heimer, Izhar Bar-Gad, Joshua A. Goldberg, and Hagai Bergman

Department of Physiology, the Interdisciplinary Center for Neural Computation and the Eric Roland Center for Neurodegenerative Diseases, The Hebrew University-Hadassah Medical School, Jerusalem, 91120 Israel

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Previous physiological studies have revealed changes in firing rates and synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease. Several primate and human studies have demonstrated that dopamine replacement therapy (DRT) reverses the changes in the pallidal firing rates; however, the effects of DRT on pallidal synchronization have never been explored. To do so, we recorded the simultaneous activity of pallidal neurons of a vervet monkey before and after induction of severe parkinsonism by systemic MPTP treatment. We subsequently recorded the pallidal activity before and after daily administration of oral DRT. We extended the time scale of our correlation studies to ±5 sec to allow detection of long-duration synchronized neuronal activity. After MPTP treatment, firing rates decreased in the external segment of the globus pallidus (GP_e) and increased in the internal segment (GP_i). A reversal of these rate changes occurred during the "on" periods of DRT. The percentage of correlated pairs increased from 16.7% in the normal state to 46.9% after MPTP treatment and was restored to nearly normal values (25% correlated pairs) under the influence of DRT. These changes in rate and correlation were observed at both the population level and at the level of units recorded continuously before, during, and after the clinical transition from "off" to "on" periods. We conclude that changes in both pallidal discharge rates and synchronization are correlated with the clinical manifestations of parkinsonism and its pharmacological treatment.

Key words: Parkinson's disease; globus pallidus; basal ganglia; monkeys; cross-correlations; L-3,4-dihydroxyphenylalanine

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Many previous studies have reported changes in the activity of globus pallidus (GP) neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys compared with healthy ones. Firing rates of the internal segment of the GP (GP_i) cells are increased, whereas the external segment of the GP (GP_e) cells display decreased firing rates (Miller and DeLong, 1987; Filion and Tremblay, 1991). Single-electrode recordings performed on human parkinsonian patients during surgical interventions designed to relieve parkinsonian symptoms indicate trends in firing rates similar to those found in primates (Hutchison et al., 1994; Merello et al., 1999).

Changes in firing synchronization have also been reported in parkinsonian subjects. Whereas in normal monkeys, activity within the basal ganglia is mostly independent, synchronous oscillations are found in MPTP monkeys (Nini et al., 1995; Raz et al., 2000) and in human parkinsonian patients (Hurtado et al., 1999; Levy et al., 2000).

Many electrophysiological studies have indicated that the changes of pallidal firing rates are reversed after administration of dopamine replacement therapy (DRT) in humans (Hutchinson et al., 1997; Merello et al., 1999; Levy et al., 2001) and primates (Filion et al., 1991; Papa et al., 1999) (but see Boraud et al., 1998). However, all of these studies were confined to the activity of single neurons. In this study, we used multiple electrode recording to examine the effect of DRT on neuronal synchronization in the two segments of the pallidum.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Animals and behavioral paradigm. A vervet monkey (Cercopithecus aethiops aethiops; female; weight, 3.8 kg) was trained to perform a button-pressing task. The monkey's health was monitored by a veterinarian, and its fluid consumption, diet, and weight were observed daily. All procedures were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (1996) and with the Hebrew University guidelines for the use and care of laboratory animals in research and were approved and supervised by the Institutional Animal Care and Use Committee.

Surgical procedures. After training, an 18 mm Cilux recording chamber was attached to the skull over a trephine hole to allow access to the GP. The recording chamber was tilted 50° laterally in the coronal plan, with its center targeted at stereotaxic coordinates A12, H1, and L9 (Contreras et al., 1981). The coordinates of the chamber were adjusted and subsequently verified with magnetic resonance imaging (Biospec Bruker 4.7 tesla animal system, fast spin echo sequence; effective echo time, 80 msec; repetition time, 2.5 sec; 13 coronal slices 2 mm wide). All surgical and magnetic resonance imaging procedures were performed under general anesthesia (induced and maintained by ketamine hydrochloride 13 mg/kg and xylazine 0.5 mg/kg i.m.).

Recording procedures and data collection. During recording sessions, the monkey's head was immobilized, and eight glass-coated tungsten microelectrodes (impedance 0.3-1.2 M at 1000 Hz), confined within a cylindrical guide (1.65 mm inner diameter), were advanced separately (EPS; Alpha-Omega Engineering, Nazareth, Israel) into the GP. The penetrations covered most of the pallidal volume. The recording boundaries extended from 2 to 4 mm anterior and from 4 to 7 mm lateral to the center of the chamber.

Each electrode signal was amplified with a gain of 5000-20,000 and bandpass filtered with a 300-6000 Hz four-pole Butterworth filter (MCP+; Alpha-Omega Engineering, Nazareth, Israel). This electrical activity was sorted and classified on-line using a template-matching algorithm (MSD; Alpha-Omega Engineering). The sampling rate of spike detection pulses and behavioral events was 12 kHz (AlphaMap, Alpha-Omega Engineering).

Cells were selected for recording only as a function of their isolation quality and optimal signal-to-noise ratio. Only stable and well isolated (as judged by stable spike waveforms and stable firing rates) units were included in this study (minimum stable recording time of 4 min). The average stable recording time was 25 ± 10.6 min (mean ± SD). The classification of each recorded cell to the external and internal pallidum was determined according to several criteria: the depth of the electrode (depths from the first pallidal unit of GP_e and GP_i cells included in the study were 0.5 ± 0.4 and 2.5 ± 0.8 mm, mean ± SD, respectively); other anatomical structures identified along the electrode trajectory; the firing pattern of the cell (which served as a criterion only in the normal state); and shape of the cell spikes. If the subclassification into GP_e and GP_i was in doubt, the units were classified as GP.

MPTP and DRT. Parkinsonism was induced by five intramuscular injections of 0.4 mg/kg of the MPTP-HCl neurotoxin (Aldrich, Milwaukee, WI) over a period of 4 d. The monkey developed severe parkinsonism 5 d after initiation of MPTP treatment, and recordings were resumed 4 d after the last injection. After 14 d of recordings in the parkinsonian state, we initiated daily DRT with starting doses of 0.5 × 25/250 mg of Dopicar [L-3,4-dihydroxyphenylalanine (L-DOPA) and carbidopa; MSD, Netherlands] in the morning and 5 mg of Parlodel (bromocryptine; Sandoz, Basel, Switzerland) divided equally between morning and evening. The drugs were administered orally as crushed powder dissolved in liquid, and the doses were slowly increased and adjusted to achieve optimal clinical response. Maximal doses attained were 1.5 × 25/250 mg of Dopicar with 2.5 mg of Parlodel in the morning and 1 × 25/250 mg of Dopicar with 2.5 mg of Parlodel in the evening. The clinical state was assessed daily in the home cage using a modified primate parkinsonism and dyskinesia scale (Imbert et al., 2000). During the recordings, DRT-"off" periods were defined as the periods before the morning dose (at least 12 hr after the evening dose). The clinical definition of the "off-on" transition was based on observation of limbs and tail movements, resumption of task performance, or appearance of involuntary dyskinetic movements (at the stage when these had already developed).

Recordings during the DRT state started 3 d after onset of treatment (21 d after the last MPTP injection). Each day, we recorded for 10-30 min in the off period. We then administered the medications while keeping the electrodes in position, and subsequently resumed the recordings. In many cases, this protocol allowed for recording of a given unit before, during, and after administration of DRT. In other cases, when units were lost during the oral administration of the drugs, it still enabled us to record the activity of other cells in the immediate vicinity of the cells studied before DRT. Although we recorded the ongoing discharge changes of cells in response to the medication, we included only the stable segments before and after these transients in the analysis. Periods of complete cessation of GP_i discharge were excluded from the analysis because of the inability to characterize the firing patterns and neuronal synchronization of cells that were virtually inactive.

Data analysis. We performed quantitative analysis of firing rates and correlated activity of the pallidal cells. Statistical tests were accepted as significant at a value of p < 0.001 unless specified otherwise. The same threshold was applied in the analysis of neural activity for all clinical states.

Only cross-correlograms of pairs recorded by different electrodes were included to avoid possible artifacts caused by a shadowing effect of high-discharge cells recorded from the same electrode (Bar-Gad et al., 2001). The correlograms were calculated for ±5000 msec offset, using 1 msec bins and recording edge correction. We tested the null hypothesis of independent activity (i.e., flat cross-correlogram) by searching either for significant peaks and troughs or for significant periodic oscillations. Baseline firing rate and SD were estimated using the first and last 500 msec of the ±5000 msec cross-correlogram. A peak or trough was considered significant if its probability (normalized to the total number of bins) was <0.001 and it was within an offset of ±250 msec from zero. The significance of the oscillatory phenomena was assessed using the Fourier transform of the cross-correlograms (power spectra). The SD of each power spectrum was calculated over the range of 1-200 Hz. A correlogram was considered to have significant periodic oscillations if the peak in the power spectrum crossed a threshold of p = 0.001 and was within the range of 3-30 Hz (Raz et al., 2000).

Histology. After the last recording session (98 d after the last MPTP injection), the monkey was killed with a lethal dose of pentobarbital and perfused through the heart with saline followed by a 4% paraformaldehyde solution. The brain of the monkey was removed, 50 µm serial sections were cut on a freezing microtome, and every 12th section was processed for Nissl or tyrosine hydroxylase immunocytochemistry.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Clinical states

The first signs of parkinsonism appeared on the third day of the MPTP treatment, in the form of bradykinesia, flexed posture, and lower limb dystonia. Akinesia and freezing developed on day 4, and tremor and rigidity appeared on day 5. By this day, the monkey had lost the ability to perform the behavioral paradigm and to self-feed. This clinical state of severe parkinsonism remained stable during all days of recording in the L-DOPA-naive MPTP monkey, with an average parkinsonism score of 30.0/36.

DRT commenced 18 d after the last MPTP injection. The first response to the therapy was observed after the third dose of medication (24 hr after initiation of treatment). The latency of on periods varied from day to day between 0.5 and 3 hr, and the duration exceeded 2 hr. The clinical effects of DRT included an increase in amount and velocity of movements, straightening of posture, and regained ability to self-feed and to partially perform the task. In addition, there was an increase in amplitude and duration of the action tremor (Vidailhet et al., 1999). After 6 weeks of daily DRT, the monkey began to exhibit peak-dose dyskinesia. The average parkinsonian scores in the off and on periods were 31.2/36 (not significantly different from the MPTP L-DOPA-naive state) and 2.9/36, respectively. Postmortem examination revealed an almost complete loss of tyrosine hydroxylase staining throughout the striatum and that the vast majority of dopaminergic neurons of the substantia nigra were lost.

Neuronal firing rates

After MPTP treatment, firing rates decreased significantly in the GP_e and increased in the GP_i cells (Table 1A). The rate changes in GP_i were significant only at a value of p < 0.05, probably because of the smaller number of cells. During DRT-off periods, these changes were augmented in the GP_e and maintained in the GP_i. The rate changes were reversed in both pallidal segments during the on periods (Table 1A, Fig. 1A).

View this table: [in this window] [in a new window]   Table 1.   Neuronal firing rates and correlation in the pallidum

View larger version (17K): [in this window] [in a new window]   Figure 1.   Summary of changes in firing rates and correlation in each clinical state. A, Changes in neuronal firing rates in the GPe and GPi proceed in opposite directions in response to dopamine depletion and replacement. After induction of parkinsonism, neuronal firing rates decrease in the GPe and increase in the GPi, and the reverse occurs in response to DRT. The y-axis is the ratio between mean firing rates of GPe and GPi neurons. MPTP, MPTP-treated L-DOPA-naive parkinsonian monkey; DRT-off, off periods (before morning dose) of MPTP monkey undergoing daily DRT; DRT-on, on periods of MPTP monkey after DRT. B, Neuronal synchronization increases after dopamine depletion and decreases in response to dopamine replacement. Neurons from both pallidal segments are pooled. The y-axis is the percentage of correlated pairs. Clinical state definitions are the same as in A.

Stable continuous recordings before and after the clinical influence of DRT were obtained in 29 GP_e and six GP_i cells (Fig. 2). The average firing rate after DRT in the continuously recorded GP_e cells increased by a factor of 2.8 (44.7 spikes/sec). Of these GP_e cells, 26 (89.7%) increased their firing rate significantly (p < 0.005, Student's t test), whereas only two cells (6.9%) decreased their firing rate significantly in the on period. The average firing rate after DRT in the continuously recorded GP_i cells decreased by a factor of 2.4 (27 spikes/sec). Among these GP_i cells, five (83.3%) decreased their firing rate significantly (p < 0.005, Student's t test), and the remaining one did not change its firing rate significantly in the on period.

View larger version (26K): [in this window] [in a new window]   Figure 2.   Discharge rates of five continuously recorded pallidal neurons during the clinical off-on transition, demonstrating an increase in discharge rate of GPe units and a decrease in GPi units. DRT was administered orally 35 min before onset of recording (solid arrow); clinical off-on transition began after 14 min of recording (open arrow). All units were recorded continuously through minutes 0-52, except for unit 6, which was recorded through minutes 8-46. The x-axis is time in minutes; y-axis is the firing rate of each unit in spikes/sec.

Neuronal synchronization

While most of the pallidal pairs were uncorrelated in the normal state, there was a significant increase in the neuronal correlation after MPTP treatment. This increase in correlation was augmented in the DRT-off periods and reversed to near normal levels in the on periods (Table 1B, Fig. 1B). The pattern of correlation also varied between the states, with a notable increase in proportion of oscillatory correlograms after MPTP. However, the fraction of oscillatory correlated pairs did not return to normal values during on periods (Table 1C). The ratio of positive (peaks) to negative (troughs) nonflat cross-correlograms (Fig. 3E) ranged from 2.2 to 3.5 throughout all clinical states.

View larger version (39K): [in this window] [in a new window]   Figure 3.   Examples of changes in neuronal synchronization in response to DRT. A, B, Simultaneous recording from the GPe of the MPTP monkey undergoing daily DRT in off period (A) and the same cells in on period 26 min later (B). The recordings show synchronized bursts in the off period but not in the on period. The x-axis is time in seconds. C, D, Temporal magnification of 2 sec from the traces shown in A and B, respectively. E, F, Cross-correlogram matrices of the units shown in A and B, demonstrating long-range cross-correlations in the off period (E) that are flattened in the on period (F). The x-axis is the offset of the cross-correlogram in seconds; y-axis is the conditional firing rate in spikes/sec. Un x, y corresponds to unit number y in electrode number x. E, Inset, Demonstrates how the cross-correlogram of units 2.1 and 4.1 crosses confidence lines when calculated for ±5 sec offset and does not cross the confidence lines when calculated for ±0.5 sec offset. x- and y-axes are the same as for E and F.

Separate analysis of GP_e pairs and GP_i pairs revealed differences in correlation level and pattern in the two nuclei (Table 1B,C). In the GP_i, there was a vast increase in percentage of correlated pairs in the MPTP compared with the normal state but no further change in the percentage of correlated pairs in the DRT-off periods. In the GP_e, however, the increase in the percentage of correlated pairs in the MPTP state compared with the normal state was moderate, with a greater increase in synchronization in the DRT-off periods. The decrease in percentage of correlated pairs in DRT-on periods was noted both among GP_e pairs and GP_i pairs (Table 1B). In addition, although the vast majority of correlated GP_i pairs were oscillatory, a significant portion of the correlated GP_e pairs exhibited nonoscillatory correlation (Table 1C).

Stable recordings of 94 pallidal pairs (42 cells, 8 recording days) were maintained during and after the off-on transition. Analysis of correlation in these pairs showed a similar reversal of abnormal correlation from 77.7% correlated pairs in the off period to 26.6% in the on period (p < 0.001, ² test). An origin-based subclassification of the 94 pairs showed that of the 62 GP_e-GP_e and GP_e-GP pairs, 47 (75.8%) were correlated before medication and only 22 (35.5%) were correlated after DRT. Among the six GP_i-GP_i and GP_i-GP pairs, five (83.3%) were correlated before medication and none after. A similar reduction in correlation was observed among the seven GP_e-GP_i pairs, from six correlated pairs before DRT to none after. Examples of typical cross-correlation matrices in consecutive off and on periods are shown in Figure 3, E and F.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

In this study, we used simultaneous multiple electrode recording to calculate the neuronal correlation during DRT of an MPTP monkey. In contrast to the ultrafast intramuscular apomorphine used in most previous studies, we used the customary oral medications (L-DOPA combined with a postsynaptic dopamine agonist) administered in clinical practice. In addition, the continuous recording of many cells before, during, and after the clinical off-on transition served to avoid potential selection bias of cells in two different clinical states. Our main findings are that (1) dopamine depletion decreases the neuronal firing rates in GP_e and increases the neuronal firing rates in GP_i, (2) dopamine depletion increases neuronal synchronization in both pallidal segments, and (3) DRT reverses all of the above changes.

Clinical effects of MPTP and DRT

The monkey developed the full clinical spectrum of MPTP-induced parkinsonism (Burns et al., 1983; Bergman et al., 1994). The responses of the monkey to DRT resembled the common effects (both therapeutic and adverse) seen in human patients. As in other primate studies (Bedard et al., 1986; Pearce et al., 1995), the doses required (in milligrams per kilogram) to achieve the optimal therapeutic response were higher than the doses used in most human patients. This could be a result of either the acute effect of MPTP (achieving a state of severe parkinsonism within a few days) or species differences, such as the higher metabolic rate of 3 kg monkeys, differences in gut absorption, activities of metabolic enzymes, and penetration of the blood-brain barrier. The appearance of dyskinesia in the monkey after only a few weeks of DRT compared with several years in parkinsonian patients has also been reported (Bedard et al., 1986; Pearce et al., 1995) and can be attributed to the same factors.

Because changes in both discharge rates and correlation appeared to proceed in the same direction in the optimal DRT state and after the development of dyskinesia, we considered the two states together in the present analysis. The higher number of observations in the grouped data serves better for the purpose of comparing the dopamine-depleted animal with the animal with DRT. The differences between optimal and dyskinetic DRT should be further investigated in future studies.

Changes in firing rates

The classic model of the basal ganglia (Albin et al., 1989; DeLong, 1990) predicts that striatal dopamine depletion will result in overactivity of GP_i neurons and reduced activity of GP_e neurons. Early MPTP primate electrophysiological studies have verified the predictions of the model in the dopamine-depleted state (Miller and DeLong, 1987; Filion and Tremblay, 1991). However, these observations have not been fully confirmed by recent studies (Boraud et al., 1998; Wichmann et al., 1999; Raz et al., 2000).

In the same manner, the prediction of the model that DRT will cause a reversal of pallidal rate changes has been verified by some but not all studies. Apomorphine injections have been reported to result in increased GP_e activity and reduced GP_i activity (Filion et al., 1991; Hutchinson et al., 1997). Other primate (Papa et al., 1999) and human (Levy et al., 2001) studies restricted to GP_i neurons alone have confirmed the predicted decrease in GP_i neuronal firing rate. However, a third study examining the effect of chronic L-DOPA treatment in MPTP monkeys demonstrated a significant decrease in GP_i firing rates but did not find a significant increase in GP_e firing rates in response to DRT (Boraud et al., 1998). Similarly, metabolic studies of animal models of parkinsonism challenge the prediction of decreased striatal inhibition of GP_e after DRT (Mitchell et al., 1992; Herrero et al., 1996; Vila et al., 1997).

Our study verified the predicted rate changes in both segments of the pallidum in the dopamine-depleted and the dopamine-replacement state (Fig. 1A, Table 1A). The conflicting earlier results, especially regarding GP_e activity, might be caused by differences in recording techniques or individual responses to MPTP. Moreover, metabolic studies could be influenced by other factors (such as firing pattern and synchronization) in addition to firing rates.

The overshooting of the firing rates beyond normal values in both pallidal segments during DRT-on periods, as well as total firing cessation of some GP_i cells, has been described before (Papa et al., 1999; Obeso et al., 2000). We ascribe this overshooting to the unregulated manner (temporally and spatially) in which dopamine is introduced to the circuitry during DRT. We further believe that these rate disturbances might serve as part of the neuronal substrate of L-DOPA-induced dyskinesia.

Changes in synchronization

Previous primate (Nini et al., 1995; Raz et al., 2000) and human (Hurtado et al., 1999; Levy et al., 2000) studies have shown an increase in neuronal synchronization in the basal ganglia of parkinsonian subjects. Our results confirm the increase in neuronal synchronization after induction of parkinsonism and show that this increased level of synchronization is maintained in the off periods of chronic DRT and reversed during DRT-on periods. The co-occurrence of the decrease in synchronization with clinical improvement supports the notion that abnormal synchronization plays a key role in the pathophysiology of parkinsonism. However, current methods fall short in evaluating the precise temporal relationships between the clinical and neuronal changes (Ben Shaul et al., 2001), and future studies on this subject are necessary.

The relatively higher proportion of correlated pairs that we found in the normal state compared with previous works (Nini et al., 1995; Raz et al., 2000) might result from slow mutual processes (Walters et al., 2000; Wichmann et al., 2002) that could not be revealed by short-time-scale cross-correlograms. Indeed, when checking our data in the normal state for significant correlations using the previously applied calculation of ±500 msec offset correlograms, we found only 7.5% (45 of 599) correlated pairs (Fig. 3E, inset). These results are not significantly different from previous reports and corroborate our claim that using a longer offset in the correlogram calculation results in a higher detection rate of correlation.

Changes in correlated activity in the various states of dopamine depletion and replacement differed for the two segments of the pallidum. Whereas in the GP_i, correlation was greatly increased after induction of parkinsonism but did not change thereafter during the DRT-off state, in the GP_e, there was a significant additional increase in correlation in the DRT-off state. This, along with a similar additional decrease in the GP_e discharge rates during DRT-off, with no corresponding change in the GP_i, might imply that the chronic effect of DRT is more prominent in the external pallidum. Such chronic effects of DRT on circuitry and neural properties could also play a role in the generation of L-DOPA-induced dyskinesia. The similarity between the percentage of correlated pairs in the total pallidal population and the percentage of correlated pairs within the GP_e is probably related to the predominance of GP_e neurons among the nonclassified GP neurons in our database.

The fact that the firing rate changes in response to DRT shift in opposite directions in GP_e and GP_i implies that the accompanying changes in correlation are not a byproduct of discharge rate changes. In contrast to previous primate and human reports (Raz et al., 2000; Levy et al., 2002), we found that a significant portion of correlated activity was nonoscillatory and wide-ranged (Table 1C, Fig. 3A,E). This discrepancy can be explained by the wider time scale used in the present study and provides strong evidence that abnormal pallidal synchronization is not a mere byproduct of the appearance of oscillations in the circuitry.

We conclude that abnormal neuronal synchronization in output nuclei of the basal ganglia is correlated with the clinical signs of parkinsonism and that the desynchronization of pallidal output might be a key factor in therapeutic manipulations of Parkinson's disease such as DRT and deep brain surgeries.

	FOOTNOTES

Received March 25, 2002; revised June 24, 2002; accepted July 1, 2002.

This Center of Excellence (8006/00) research was supported by the Israel Science Foundation. It was also supported by the United States-Israel Binational Science Foundation, the German-Israel Binational Foundation, and the Joint German-Israel Research Program. V. Sharkansky provided technical support. We thank G. Goelman (Hadassah Hospital, Jerusalem) for assistance with the magnetic resonance imaging and S. Haber (University of Rochester) for help with the histological studies. We thank E. Vaadia and S. Hocherman for critical reading.

Correspondence should be addressed to Gali Heimer, Department of Physiology, The Hebrew University-Hadassah Medical School, P.O. Box 12272, Jerusalem, 91120 Israel. E-mail: galih{at}md.huji.ac.il.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

• Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375[ISI][Medline].
• Bar-Gad I, Ritov Y, Bergman H (2001) Failure in identification of overlapping spikes from multiple neuron activity causes artificial correlations. J Neurosci Methods 107:1-13[ISI][Medline].
• Bedard PJ, Di Paolo T, Falardeau P, Boucher R (1986) Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys: correlation with [3H]spiperone binding. Brain Res 379:294-299[ISI][Medline].
• Ben Shaul Y, Bergman H, Ritov Y, Abeles M (2001) Trial to trial variability in either stimulus or action causes apparent correlation and synchrony in neuronal activity. J Neurosci Methods 111:99-110[ISI][Medline].
• Bergman H, Wichmann T, Karmon B, DeLong MR (1994) The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72:507-520[Abstract/Free Full Text].
• Boraud T, Bezard E, Guehl D, Bioulac B, Gross C (1998) Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GP_e) and globus pallidus internalis (GP_i) in the MPTP-treated monkey. Brain Res 787:157-160[ISI][Medline].
• Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550[Abstract/Free Full Text].
• Contreras CM, Mexicano G, Guzman-Flores CA (1981) Stereotaxic brain atlas of the green monkey (Cercopithecus aethiops aethiops). Bol Estud Med Biol 31:383-428[Medline].
• DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285[ISI][Medline].
• Filion M, Tremblay L (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547:142-151[ISI][Medline].
• Filion M, Tremblay L, Bedard PJ (1991) Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547:152-161[ISI][Medline].
• Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC (1996) Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47:219-224[Abstract/Free Full Text].
• Hurtado JM, Gray CM, Tamas LB, Sigvardt KA (1999) Dynamics of tremor-related oscillations in the human globus pallidus: a single case study. Proc Natl Acad Sci USA 96:1674-1679[Abstract/Free Full Text].
• Hutchison WD, Lozano AM, Davis KD, Saint Cyr JA, Lang AE, Dostrovsky JO (1994) Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients. NeuroReport 5:1533-1537[ISI][Medline].
• Hutchinson WD, Levy R, Dostrovsky JO, Lozano AM, Lang AE (1997) Effects of apomorphine on globus pallidus neurons in parkinsonian patients. Ann Neurol 42:767-775[ISI][Medline].
• Imbert C, Bezard E, Guitraud S, Boraud T, Gross CE (2000) Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the macaque monkey. J Neurosci Methods 96:71-76[ISI][Medline].
• Levy R, Hutchison WD, Lozano AM, Dostrovsky JO (2000) High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci 20:7766-7775[Abstract/Free Full Text].
• Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano AM (2001) Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease. J Neurophysiol 86:249-260[Abstract/Free Full Text].
• Levy R, Hutchison WD, Lozano AM, Dostrovsky JO (2002) Synchronized neuronal discharge in the basal ganglia of parkinsonian patients is limited to oscillatory activity. J Neurosci 22:2855-2861[Abstract/Free Full Text].
• Merello M, Balej J, Delfino M, Cammarota A, Betti O, Leiguarda R (1999) Apomorphine induces changes in GP_i spontaneous outflow in patients with Parkinson's disease. Mov Disord 14:45-49[ISI][Medline].
• Miller WC, DeLong MR (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: The basal ganglia II (Carpenter MB, Jayaraman A, eds), pp 415-427. New York: Plenum.
• Mitchell IJ, Boyce S, Sambrook MA, Crossman AR (1992) A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain: implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. Brain 115:809-824[Abstract/Free Full Text].
• Nini A, Feingold A, Slovin H, Bergman H (1995) Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophysiol 74:1800-1805[Abstract/Free Full Text].
• Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW (2000) Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23:S8-S19[ISI][Medline].
• Papa SM, DeSimone R, Fiorani M, Oldfield EH (1999) Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann Neurol 46:732-738[ISI][Medline].
• Pearce RK, Jackson M, Smith L, Jenner P, Marsden CD (1995) Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus). Mov Disord 10:731-740[ISI][Medline].
• Raz A, Vaadia E, Bergman H (2000) Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 20:8559-8571[Abstract/Free Full Text].
• Vidailhet M, Bonnet AM, Marconi R, Durif F, Agid Y (1999) The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease. Mov Disord 14 [Suppl 1]:13-18.
• Vila M, Levy R, Herrero MT, Ruberg M, Faucheux B, Obeso JA, Agid Y, Hirsch EC (1997) Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 17:765-773[Abstract/Free Full Text].
• Walters JR, Ruskin DN, Allers KA, Bergstrom DA (2000) Pre- and postsynaptic aspects of dopamine-mediated transmission. Trends Neurosci 23:S41-S47[ISI][Medline].
• Wichmann T, Bergman H, Starr PA, Subramanian T, Watts RL, DeLong MR (1999) Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res 125:397-409[ISI][Medline].
• Wichmann T, Kliem MA, Soares JC (2002) Slow oscillatory discharge in the primate basal ganglia. J Neurophysiol 87:1145-1148[Abstract/Free Full Text].

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22187850-06$05.00/0

This article has been cited by other articles:

				J. Baufreton and M. D. Bevan D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus J. Physiol., April 15, 2008; 586(8): 2121 - 2142. [Abstract] [Full Text] [PDF]

				S. Ramanathan, T. Tkatch, J. F. Atherton, C. J. Wilson, and M. D. Bevan D2-Like Dopamine Receptors Modulate SKCa Channel Function in Subthalamic Nucleus Neurons Through Inhibition of Cav2.2 Channels J Neurophysiol, February 1, 2008; 99(2): 442 - 459. [Abstract] [Full Text] [PDF]

				M. Rivlin-Etzion, O. Marmor, G. Saban, B. Rosin, S. N. Haber, E. Vaadia, Y. Prut, and H. Bergman Low-Pass Filter Properties of Basal Ganglia Cortical Muscle Loops in the Normal and MPTP Primate Model of Parkinsonism J. Neurosci., January 16, 2008; 28(3): 633 - 649. [Abstract] [Full Text] [PDF]

				J. K. H. Tang, E. Moro, N. Mahant, W. D. Hutchison, A. E. Lang, A. M. Lozano, and J. O. Dostrovsky Neuronal Firing Rates and Patterns in the Globus Pallidus Internus of Patients With Cervical Dystonia Differ From Those With Parkinson's Disease J Neurophysiol, August 1, 2007; 98(2): 720 - 729. [Abstract] [Full Text] [PDF]

				S. Elias, M. Joshua, J. A. Goldberg, G. Heimer, D. Arkadir, G. Morris, and H. Bergman Statistical Properties of Pauses of the High-Frequency Discharge Neurons in the External Segment of the Globus Pallidus J. Neurosci., March 7, 2007; 27(10): 2525 - 2538. [Abstract] [Full Text] [PDF]

				G. Heimer, M. Rivlin-Etzion, I. Bar-Gad, J. A. Goldberg, S. N. Haber, and H. Bergman Dopamine Replacement Therapy Does Not Restore the Full Spectrum of Normal Pallidal Activity in the 1-Methyl-4-Phenyl-1,2,3,6-Tetra-Hydropyridine Primate Model of Parkinsonism J. Neurosci., August 2, 2006; 26(31): 8101 - 8114. [Abstract] [Full Text] [PDF]

				F. Alonso-Frech, I. Zamarbide, M. Alegre, M. C. Rodriguez-Oroz, J. Guridi, M. Manrique, M. Valencia, J. Artieda, and J. A. Obeso Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease Brain, July 1, 2006; 129(7): 1748 - 1757. [Abstract] [Full Text] [PDF]

				M. Rivlin-Etzion, Y. Ritov, G. Heimer, H. Bergman, and I. Bar-Gad Local Shuffling of Spike Trains Boosts the Accuracy of Spike Train Spectral Analysis J Neurophysiol, May 1, 2006; 95(5): 3245 - 3256. [Abstract] [Full Text] [PDF]

				T. Wichmann and J. Soares Neuronal Firing Before and After Burst Discharges in the Monkey Basal Ganglia Is Predictably Patterned in the Normal State and Altered in Parkinsonism J Neurophysiol, April 1, 2006; 95(4): 2120 - 2133. [Abstract] [Full Text] [PDF]

				S. Marceglia, G. Foffani, A. M. Bianchi, G. Baselli, F. Tamma, M. Egidi, and A. Priori Dopamine-dependent non-linear correlation between subthalamic rhythms in Parkinson's disease J. Physiol., March 15, 2006; 571(3): 579 - 591. [Abstract] [Full Text] [PDF]

				M. Pessiglione, V. Czernecki, B. Pillon, B. Dubois, M. Schupbach, Y. Agid, and L. Tremblay An Effect of Dopamine Depletion on Decision-making: The Temporal Coupling of Deliberation and Execution J. Cogn. Neurosci., December 1, 2005; 17(12): 1886 - 1896. [Abstract] [Full Text] [PDF]

				W. Meissner, A. Leblois, D. Hansel, B. Bioulac, C. E. Gross, A. Benazzouz, and T. Boraud Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations Brain, October 1, 2005; 128(10): 2372 - 2382. [Abstract] [Full Text] [PDF]

				K. C Loucif, C. L Wilson, R Baig, M. G Lacey, and I. M Stanford Functional interconnectivity between the globus pallidus and the subthalamic nucleus in the mouse brain slice J. Physiol., September 15, 2005; 567(3): 977 - 987. [Abstract] [Full Text] [PDF]

				L. C. Parr-Brownlie and B. I. Hyland Bradykinesia Induced by Dopamine D2 Receptor Blockade Is Associated with Reduced Motor Cortex Activity in the Rat J. Neurosci., June 15, 2005; 25(24): 5700 - 5709. [Abstract] [Full Text] [PDF]

				G. F. Molnar, A. Pilliar, A. M. Lozano, and J. O. Dostrovsky Differences in Neuronal Firing Rates in Pallidal and Cerebellar Receiving Areas of Thalamus in Patients With Parkinson's Disease, Essential Tremor, and Pain J Neurophysiol, June 1, 2005; 93(6): 3094 - 3101. [Abstract] [Full Text] [PDF]

				A. Nevet, G. Morris, G. Saban, N. Fainstein, and H. Bergman Discharge Rate of Substantia Nigra Pars Reticulata Neurons Is Reduced In Non-Parkinsonian Monkeys With Apomorphine-Induced Orofacial Dyskinesia J Neurophysiol, October 1, 2004; 92(4): 1973 - 1981. [Abstract] [Full Text] [PDF]

				M. P. Hill, P. Ravenscroft, E. Bezard, A. R. Crossman, J. M. Brotchie, A. Michel, R. Grimee, and H. Klitgaard Levetiracetam Potentiates the Antidyskinetic Action of Amantadine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson's Disease J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 386 - 394. [Abstract] [Full Text] [PDF]

				J. A. Goldberg, U. Rokni, T. Boraud, E. Vaadia, and H. Bergman Spike Synchronization in the Cortex-Basal Ganglia Networks of Parkinsonian Primates Reflects Global Dynamics of the Local Field Potentials J. Neurosci., June 30, 2004; 24(26): 6003 - 6010. [Abstract] [Full Text] [PDF]

				R. Courtemanche, N. Fujii, and A. M. Graybiel Synchronous, Focally Modulated {beta}-Band Oscillations Characterize Local Field Potential Activity in the Striatum of Awake Behaving Monkeys J. Neurosci., December 17, 2003; 23(37): 11741 - 11752. [Abstract] [Full Text] [PDF]

				D. Williams, A. Kuhn, A. Kupsch, M. Tijssen, G. van Bruggen, H. Speelman, G. Hotton, K. Yarrow, and P. Brown Behavioural cues are associated with modulations of synchronous oscillations in the human subthalamic nucleus Brain, September 1, 2003; 126(9): 1975 - 1985. [Abstract] [Full Text] [PDF]

				I. Bar-Gad, G. Heimer, Y.'a. Ritov, and H. Bergman Functional Correlations between Neighboring Neurons in the Primate Globus Pallidus Are Weak or Nonexistent J. Neurosci., May 15, 2003; 23(10): 4012 - 4016. [Abstract] [Full Text] [PDF]

</ This Article Abstract Full Text (PDF) Submit an eLetter